![Ercem Atillasoy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ercem Atillasoy is currently the Chief Regulatory & Safety Officer at Viracyte, Inc. Prior to this, he held the position of Vice President at Merck Research Laboratories Massachusetts LLC.
From 2020 to 2022, he served as the Chief Regulatory & Safety Officer at AlloVir, Inc. Dr. Atillasoy completed his undergraduate degree at City University of New York and also studied at Yale School of Medicine.
| Sociétés | Poste | Début |
|---|---|---|
Viracyte, Inc.
 Viracyte, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Conseiller Juridique Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ALLOVIRPAR | Corporate Officer/Principal | 01/10/2022 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
City University of New York
 City University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AlloVir, Inc.
 AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Viracyte, Inc.
Viracyte, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
